Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: A Study of SPY072 in Rheumatic Disease [Phase 2]

View source ↗

Summary

This clinical trials update outlines a Phase 2 study of SPY072 for rheumatoid arthritis and psoriatic arthritis, with ongoing recruitment and mention of axial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPY072

Snippet

Sponsor: Spyre Therapeutics, Inc. | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Phase 2 | Status: RECRUITING